Status:
COMPLETED
Early Identification and Treatment of Early HIV Infection in Côte d'Ivoire
Lead Sponsor:
ANRS, Emerging Infectious Diseases
Conditions:
HIV Infection
Eligibility:
All Genders
18+ years
Brief Summary
Set-up of a biobank for patients with an estimated date of infection seroconverters: store plasma and cells samples at initial contact and during follow-up for future analysis and analysis in internat...
Eligibility Criteria
Inclusion
- patients included in the last Primo-CI ANRS 1220 protocol
- All HIV infected individuals diagnosed during a blood donation with an estimated date of HIV seroconversion that will respect the following criteria: (i) age ≥18 (ii) HIV-1 or HIV-1+2 infected, (iii) HIV-seronegative at the preceding donation; (iv) who returned to the clinic to be informed of their HIV test result (v) with an HIV serology confirmed with two specific tests in two different laboratories (vi) who have never received ART for curative purpose
- informed on study objectives and have a signed informed consent.
Exclusion
- Patient living outside of Abidjan
Key Trial Info
Start Date :
June 1 1997
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2018
Estimated Enrollment :
511 Patients enrolled
Trial Details
Trial ID
NCT01917175
Start Date
June 1 1997
End Date
September 1 2018
Last Update
June 11 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Médical du Suivi des Donneurs de Sang (Blood Bank Medical Centre)
Abidjan, Côte d’Ivoire
2
Centre National de Transfusion Sanguine (National Blood Transfusion Centre)
Abidjan, Côte d’Ivoire